Stay updated on MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Sign up to get notified when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.

Latest updates to the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications notes updated to clarify that entries are provided voluntarily and may pertain to study results, are auto-filled from PubMed and may not be about the study, and the revision is now v3.3.2 (replacing the previous v3.2.0 wording).SummaryDifference0.2%

- Check19 days agoChange DetectedThe government funding status notice about potential delays and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedCore study content appears unchanged; the screenshots show only superficial UI adjustments with no updates to the Brief Summary, Eligibility Criteria, Interventions, outcomes, or key dates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check69 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check84 days agoChange DetectedUpdated page from v3.0.1 to v3.0.2 with no substantive content changes; removal of 'Back to Top' is a minor navigation tweak.SummaryDifference0.2%

Stay in the know with updates to MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the MK-3222-010 Clinical Trial: Psoriasis Efficacy & Safety page.